Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Biocon Limited ( (IN:BIOCON) ) has shared an announcement.
Biocon Limited announced that India Ratings and Research has assigned and affirmed credit ratings for the company’s various debt instruments. The ratings reflect a stable outlook for the bank loan facilities and high creditworthiness for proposed commercial papers, indicating a positive financial position and potential for growth.
More about Biocon Limited
Biocon Limited is a prominent player in the biotechnology industry, primarily focusing on the development and manufacturing of biopharmaceuticals. The company is known for its innovative solutions in healthcare, catering to a global market with a strong emphasis on research and development.
Average Trading Volume: 140,745
Technical Sentiment Signal: Strong Buy
Current Market Cap: 512.5B INR
For a thorough assessment of BIOCON stock, go to TipRanks’ Stock Analysis page.

